share_log

TransCode Therapeutics Collaborates With Debiopharm; Financial Terms Not Disclosed

TransCode Therapeutics Collaborates With Debiopharm; Financial Terms Not Disclosed

TransCode Therapeutics 與 Debiopharm 合作;財務條款未披露
Moomoo 24/7 ·  01/29 08:40

The collaboration will explore combining TransCode's proprietary TTX delivery platform with Debiopharm's expertise in targeted drug delivery to co-develop targeted nucleic acid therapeutics for cancer.

此次合作將探索將TransCode專有的TTX交付平台與Debiopharm在靶向藥物遞送方面的專業知識相結合,共同開發針對癌症的靶向核酸療法。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論